Heidelberg Pharma AG (ETR:HPHA)

Heidelberg Pharma AG Financials Overview

Financials in millions EUR. Fiscal year is December - November.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 31, 2026	Nov 30, 2025	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021
Revenue Revenue Growth	7.45	1.46	6.85	9.86	18.51	2.03
Revenue Growth	77.97%	-78.72%	-30.53%	-46.75%	810.30%	-76.53%
Gross Profit Gross Profit Growth	6.51	1.19	5.07	6.61	13.83	-2.68
Operating Income Operating Income Growth	-37.25	-48.93	-21.83	-27.55	-18.29	-25.84
Net Income Net Income Growth	-33.1	-42.28	-19.38	-20.35	-19.7	-26.14
Earnings Per Share EPS Growth	-0.71	-0.91	-0.42	-0.44	-0.53	-0.80
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Chart

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 30, 2025	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021
Germany Germany Growth	0.01	0.03	0.06	0.55	0.48
USA USA Growth	0.29	2.14	4.67	8.98	1.12
China China Growth	1.17	4.67	4.74	8.2	-
Total Total Growth	1.46	6.85	9.86	18.51	1.75

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 31, 2026	Nov 30, 2025	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021
Cash & Investments Cash & Investments Growth	24.93	14.98	29.42	43.44	81.33	6.14
Total Debt Total Debt Growth	0.05	0.11	0.16	5.83	15.98	10.63
Net Cash (Debt) Net Cash Growth	24.88	14.86	29.26	37.61	65.35	-4.49
Net Cash Growth	-24.89%	-49.20%	-22.20%	-42.45%	-	-
Net Cash Per Share Net Cash Per Share Growth	0.53	0.32	0.63	0.81	1.76	-0.14

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 31, 2026	Nov 30, 2025	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021
Operating Cash Flow Operating Cash Flow Growth	-24.8	-31.6	-29.59	-33.67	-8.86	-26.61
Capital Expenditures CapEx Growth	-0.06	-0.13	-0.46	-0.94	-0.58	-1.24
Free Cash Flow Free Cash Flow Growth	-24.86	-31.73	-30.04	-34.61	-9.45	-27.85
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 31, 2026	Nov 30, 2025	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021
Gross Margin	87.49%	81.31%	74.00%	67.01%	74.72%	-131.69%
Operating Margin	-500.35%	-3357.60%	-318.71%	-279.41%	-98.81%	-1270.65%
Pretax Margin	-424.80%	-2829.08%	-282.98%	-206.38%	-96.07%	-1285.20%
Profit Margin	-444.62%	-2901.15%	-282.98%	-206.38%	-106.42%	-1285.20%
FCF Margin	-333.95%	-2177.08%	-438.64%	-351.07%	-51.03%	-1369.57%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 6, 2026	Nov 30, 2025	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021
PS Ratio	15.96	93.41	16.33	13.05	14.39	87.04

Data Source: S&P Global Market Intelligence Last updated: May 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 5, 2026

Data Sources Report a data error